[1] |
Nijsten T, Wakkee M. Complexity of the association between psoriasis and comorbidities[J]. J Invest Dermatol, 2009,129(7):1601⁃1603. doi: 10.1038/jid.2009.55.
|
[2] |
Amin M, Lee EB, Tsai TF, et al. Psoriasis and co⁃morbidity[J]. Acta Derm Venereol, 2020,100(3):adv00033. doi: 10.2340/00015555⁃3387.
|
[3] |
Abuabara K, Azfar RS, Shin DB, et al. Cause⁃specific mortality in patients with severe psoriasis: a population⁃based cohort study in the U.K[J]. Br J Dermatol, 2010,163(3):586⁃592. doi: 10.1111/j.1365⁃2133.2010.09941.x.
|
[4] |
Skov L, Thomsen SF, Kristensen LE, et al. Cause⁃specific mortality in patients with psoriasis and psoriatic arthritis[J]. Br J Dermatol, 2019,180(1):100⁃107. doi: 10.1111/bjd.16919.
|
[5] |
Ma C, Harskamp CT, Armstrong EJ, et al. The association between psoriasis and dyslipidaemia: a systematic review[J]. Br J Dermatol, 2013,168(3):486⁃495. doi: 10.1111/bjd.12101.
|
[6] |
Fernández⁃Armenteros JM, Gómez⁃Arbonés X, Buti⁃Soler M, et al. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population⁃based study[J]. J Eur Acad Dermatol Venereol, 2019,33(1):128⁃135. doi: 10.1111/jdv.15159.
|
[7] |
Shah K, Mellars L, Changolkar A, et al. Real⁃world burden of comorbidities in US patients with psoriasis[J]. J Am Acad Dermatol, 2017,77(2):287⁃292.e4. doi: 10.1016/j.jaad.2017.03. 037.
|
[8] |
中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南(2018完整版)[J]. 中华皮肤科杂志, 2019,52(10):667⁃710. doi: 10.35541/cjd.20190847.
|
[9] |
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华全科医师杂志, 2017,16(1):15⁃35. doi: 10.3760/cma.j.issn.1671⁃7368.2017.01. 006.
|
[10] |
中国医师协会肾脏内科医师分会. 中国肾脏疾病高尿酸血症诊治的实践指南(2017版)[J]. 中华医学杂志, 2017,97(25):1927⁃1936. doi: 10.3760/cma.j.issn.0376⁃2491.2017.25.003.
|
[11] |
Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis[J]. Br J Dermatol, 2008,159(4):895⁃902. doi: 10.1111/j.1365⁃2133.2008.08707.x.
|
[12] |
Miao C, Li J, Li Y, et al. Obesity and dyslipidemia in patients with psoriasis: a case⁃control study[J]. Medicine (Baltimore), 2019,98(31):e16323. doi: 10.1097/MD.0000000000016323.
|
[13] |
Salihbegovic EM, Hadzigrahic N, Suljagic E, et al. Psoriasis and dyslipidemia[J]. Mater Sociomed, 2015,27(1):15⁃17. doi: 10. 5455/msm.2014.27.15⁃17.
|
[14] |
Nakhwa YC, Rashmi R, Basavaraj KH. Dyslipidemia in psoriasis: a case controlled study[J]. Int Sch Res Notices, 2014,2014:729157. doi: 10.1155/2014/729157.
|
[15] |
Greenberg R, Goldsmith T, Zeltser D, et al. Comorbidities in patients with palmoplantar plaque psoriasis[J]. J Am Acad Dermatol, 2021,84(3):639⁃643. doi: 10.1016/j.jaad.2020.03.112.
|